Position in VCEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,976,715
+$2,843,275 QoQ
Shares Held
404,062
-14.1% QoQ
Ownership
0.789%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. VCEL ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,976,715 | 404,062 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,133,440 | 470,421 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,125,001 | 697,723 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $17,363,915 | 551,761 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $19,913,907 | 468,012 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $25,301,991 | 567,055 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $29,109,763 | 530,136 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $21,310,896 | 504,400 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $20,892,187 | 455,366 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $23,838,680 | 458,260 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $46,216,292 | 1,297,846 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $45,467,396 | 1,356,426 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $24,952,713 | 664,166 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,600,421 | 566,181 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,050,123 | 1,026,960 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $34,527,141 | 1,488,239 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,143,334 | 1,673,683 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $25,045,181 | 655,290 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,155,026 | 283,843 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,909,803 | 285,037 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,631,138 | 297,736 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $17,201,055 | 309,650 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,638,056 | 214,963 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $560,179 | 30,231 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,886,981 | 136,540 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $400,903 | 43,719 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||